Business Resilience
During 2024 we completed the first phases of our continental European hub in the Netherlands and our new high tech distribution centre in Dublin. We also ramped up the operational use of our new warehouse in North Carolina that was opened during 2023. These new centres, together with our investment in technology, provide us with a platform to maximise the potential growth in our business. The Group continues to implement its digital transformation strategy, which includes backoffice systems to support our expansion and growth plans, as well as new ways to engage our customers with innovative digital solutions. Our Cybersecurity programme is continually updated to take into account the changing cyber-threat landscape and to address emerging risks. Our programme puts in place a defence-in-depth, multi-layer security control environment, enabling us to protect, detect, respond and recover from cyber-threats. This multi-pronged approach involves strengthening existing controls, adding additional controls where weaknesses are identified and developing strategic partnerships with technology providers to deploy market leading defensive capabilities.
Innovation
Uniphar’s innovative culture is evident in many aspects of how we do business, including identifying new opportunities, improving our services, evaluating potential acquisitions, collaborating across our many different teams and targets, and enhancing our digital capabilities.

Case Study: Medicine Shortages Impacting Patient Care

The Challenge:

In May 2024, a critical shortage of a specific pharmaceutical product arose in the Irish and UK markets. This shortage posed a potential risk to patient care in hospitals and community pharmacies across both countries.

Our Solution:

We leveraged our extensive network across the Group to identify if the product could be sourced from alternative markets or channels. Our team confirmed that the product was available in Germany and could be supplied from there. The multinational sourcing team arranged the procurement and delivery of the product from Germany into the Irish and UK markets within a few days ensuring that patients could continue to access essential care. Thanks to our global sourcing and supply chain, we can react to critical shortages and provide unlicensed and short supply medicines both within and outside Europe. This case highlights the strength and agility of our global operations, showcasing the resilience of Uniphar’s global supply solutions.